Peoples and Rundel argue that oceanic experiences in psychedelic-assisted treatment need not indicate regression but may reflect expansions of consciousness. I respond by examining how the self enables survival yet contributes to suffering, distinguishing expanded states from perspective, and proposing perspective as the hinge that transforms transient ego-dissolution into lasting growth. I...
This article critically examines the 'Tuci' (or "pink cocaine") phenomenon as an epistemic, cultural, and pharmacopolitical object, proposing its conceptualization as a monstrous substance. Two common assumptions in institutional and media discourses are problematized: that 'Tuci' is a counterfeit of 2C-B and that its identity is defined by the presence of ketamine. Using an approach that...
Our results suggest that NMDAR antagonism improves alpha and beta cell function and viability, which may have translational relevance to comorbid metabolic dysfunction in depression. These mechanisms may subserve the antidepressant effects of select NMDA antagonists (e.g., ketamine/esketamine, dextromethorphan). Further research should aim to investigate the effects of subanesthetic doses of...
HealthcareOctober 23, 2025Eve E. Keighley, Eid Abo Hamza, Dalia A Bedewy et al.1 citation
Objectives: This study investigates psychedelic drugs to treat substance use disorder (SUD). Researchers have recently begun conducting clinical trials of psychedelic treatment for SUD. The current meta-analysis investigates the extent of efficacy in alleviating SM behaviours (P) using psychedelic therapy (I), concurrent with determining which psychedelic enables the greatest effect (C) as a...
Humans have long used various substances to enhance sexual pleasure and performance, often at the expense of their overall health. This review investigates the sexual-related effects of recreational drugs, including amphetamines, 3,4-methylenedioxymethamphetamine (MDMA), mephedrone, gamma-hydroxybutyrate (GHB), and ketamine. By examining anecdotal evidence, self-reports, and limited scientific...
Objetivo: Analisar a evidência clínica e o racional neurobiológico do uso da cetamina assistida por psicoterapia no tratamento da depressão resistente. Revisão bibliográfica: A depressão resistente ao tratamento (DRT) caracteriza-se pela persistência de sintomas depressivos após falha em pelo menos dois tratamentos antidepressivos adequados, associando-se a prejuízos funcionais, sofrimento...
After years of restrictions due to concerns about their potentially harmful effects, research on psychedelics has entered a new era. Increasing attention has been directed toward their immense therapeutic potential, particularly for psychiatric disorders. Pre-clinical and clinical studies have consistently demonstrated that psychedelic treatments produce therapeutic effects within hours of...
Treatment-resistant depression (TRD) remains a major therapeutic challenge in psychiatry, affecting a substantial proportion of individuals diagnosed with major depressive disorder and contributing significantly to the overall burden of mental illness. Despite decades of research and the availability of numerous antidepressant agents, many patients fail to achieve full remission, which...
Psychedelics, such as psilocybin, lysergic acid diethylamide (LSD), ketamine, and N,N-dimethyltryptamine (DMT), have captured the attention of scientists, artists, and seekers alike for their profound ability to alter consciousness and inspire creativity. The concept of "creation" encompasses multiple interpretations-ranging from generating novel ideas to fostering personal transformation. This...
Background: Substance use disorders (SUDs) are highly prevalent, affecting over 48.5 million Americans. Available treatments for SUD remain insufficient, and many patients do not respond to existing interventions despite adequate adherence to treatments. While novel therapies for SUD are urgently needed, the use of psychedelic drugs for the treatment of SUDs has shown promise. Objectives: This...